The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

Individuals who consumed psilocybin in a therapeutic context reported modest, sustained improvements in sleep, with baseline ...

Theta burst stimulation (TBS) is a non-invasive brain stimulation technique known for modifying human behavior and treating ...

A patient in the UK has received a new therapy for Huntington’s disease, which experts hope could slow progression of the ...

The Department of Veterans Affairs has authorized a study on the use of a popular psychedelic drug to treat veterans ...

The right of transgender minors to access gender-affirming care has sparked debate in many parts of the United States, and it ...

When Tennessee banned gender-affirming care for transgender youth last year, Sarah began taking days off work to drive ...

On Wednesday, the Supreme Court will hear arguments in a case involving Tennessee's ban on gender-affirming care for ...

Chinese doctors say affordable procedure works in ‘60 to 80 per cent’ of patients, but some medical experts are sceptical.

The Supreme Court will consider if states can keep transgender adolescents from puberty blockers and hormone therapy, a major ...